Nanomedicine Market (By Application: Drug Delivery; By Indication: Clinical Oncology, Infectious Diseases, Clinical Cardiology, Orthopedics; By Molecule Type) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2023-2032

The global nanomedicine market was estimated at USD 178.29 billion in 2022 and it is expected to surpass around USD 541.99 billion by 2032, poised to grow at a CAGR of 11.76% from 2023 to 2032.

Nanomedicine Market Size 2023 to 2032

Key Pointers

  • The therapeutics segment is anticipated to witness a significant growth rate of 14.17% from 2023-2032.
  • The drug delivery market contributed significantly to the overall market in 2022.
  • The clinical oncology segment dominated the nanomedicine market with revenue of USD 52.98 billionin 2022 and exhibits the fastest growth rate during the projected period.
  • The nanoparticles segment held the highest share of 75.2% in 2022, accounting for the fastest growth rate throughout the forecast period.
  • North America dominated the regional market with a share of 47.6% in 2022.
  • In the upcoming years, the expansion of the nanomedicine market in Asia Pacific is anticipated to be significantly impacted.

Report Scope of the Nanomedicine Market

Report Coverage Details
Market Size in 2022 USD 178.29 billion
Revenue Forecast by 2032 USD 541.99 billion
Growth rate from 2023 to 2032 CAGR of 11.76%
Base Year 2022
Forecast Period 2023 to 2032
Regions Covered North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Companies Covered Abbott Laboratories; Combi Matrix Corporation; Celgene Corporation; Nano spectra Biosciences, Inc.;General Electric; Johnson & Johnson Services; Inc.; Mallinckrodt Pharmaceuticals;Merck & Co., Inc.;Pfizer, Inc.; Teva Pharmaceutical Industries Ltd.; Arrowhead Pharmaceuticals, Inc.


Development and commercialization of the techniques that holds potential to significantly improve the administration of drugs and disease management is expected to drive the adoption of nanomedicines in this market. Furthermore, growing adoption of nanotechnology-based drug delivery methods coupled with inefficiency of conventional therapeutics in disease treatment has driven the nanomedicine market growth.

According to the reports, COVID-19 has a positive effect on the market for nanomedicine. This resulted from an increase in the need for nanomedicines used for the treatment of medical conditions that resemble cancer. Additionally, applications of nanomedicine opened up new possibilities for the introduction of innovative solutions designed for the prevention, detection, and treatment of viral diseases such as the COVID-19 virus thereby boosting the nanomedicine industry growth.

Furthermore, the active participation of well-established pharmaceutical companies in the development of novel Nano science-based therapeutics is anticipated to influence the growth of this market. Moreover, advancements in nanotechnology and its expanding applications in preventive interventions, early disease diagnosis, prevention of chronic as well as acute disorders, and prophylaxis of acute as well as chronic disorders are the factors expected to spur the nanomedicine industry growth.

Manufacturers are benefiting from significant growth prospects in the global market as a result of the growing demand for nanomedicines. The field of nanomedicine is growing in the healthcare sector and is being more widely used in medical and healthcare settings. Furthermore, it is projected that the active involvement of prominent pharmaceutical companies in the production of cutting-edge nanoscience-based medicines will have an impact on the development of this industry.

Government organizations are likely to increase their R&D funding, opening up attractive opportunities for the nanomedicine market expansion. Governmental funding aids in accelerating massive capital-intensive projects. For instance, the National Science Foundation stated in August 2020 that it will invest a total of $84 million during five years in re-establishing the National Nanotechnology Coordinated Infrastructure in order to advance Nano scale engineering, science, and technology.

Moreover, The Canadian Institutes of Health Research (CIHR) and the Canadian Space Agency (CSA) are funded by the Canadian government for research in the field of nanomedicine and regenerative medicine. Therefore, it will drive the nanomedicine market growth in the coming years.

Regional Insights

North America dominated the regional market with a share of 47.58% in 2021. During the course of the forecast period, the region is expected to retain its leadership. This expansion can be ascribed to the existence of expanding alliances between businesses working in this area and nanomedicine start-up companies. Furthermore, the region's significant participation in the industrial sector is due to the support from governmental bodies combined with increased R&D expenditures.

The expansion of the market is driven by an increase in research funding and a rise in demand for life-threatening illness prophylaxis in the United States. The nation also boasts a sizable number of manufacturing firms with active strategic ventures in nanomedicine.

Nanomedicine Market Segmentations:

By Application

  • Therapeutics
  • Active Implants
  • In-vitro Diagnostics
  • Drug Delivery
  • In-vivo Imaging
  • Implants

By Indication

  • Clinical Oncology
  • Infectious diseases
  • Clinical Cardiology
  • Orthopedics
  • Others

By Molecule Type

  • Nanoparticles
    • Metal & Metal Oxide Nanoparticles
    • Liposomes
    • Polymers & Polymer Drug Conjugates
    • Hydrogel Nanoparticles
    • Dendrimers
    • Inorganic Nanoparticles
  • Nano Shells
  • Nano Tubes
  • Nano Devices

Frequently Asked Questions

The global nanomedicine market size was reached at USD 178.29 billion in 2022 and it is projected to hit around USD 541.99 billion by 2032.

The global nanomedicine market is growing at a compound annual growth rate (CAGR) of 11.76% from 2023 to 2032.

The North America region has accounted for the largest nanomedicine market share in 2022.

Report Detail

Proceed To Buy

USD 4500
USD 7900

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers